tirzepatide and binge eating disorder Weight-loss drugs may help reduce symptoms of disorder, research finds Binge ED Recovery: My Mounjaro

Human Trials in Progress There are a number of clinical trials currently underway or being planned for GLP-1s, including a trial that Novo Nordisk just announced of Wegovy and alcohol use / liver disease

Mackus M, Stock A, Garssen J, et

Many personalized tirzepatide prescriptions include a small addition of vitamin B12, added to support energy levels during a period of reduced calorie intake

B., Hangoc, G., Liu, Y., Pollok, K., & Broxmeyer, H

Treatment with RFA tends to last around 9 months on average (give or take 3 months), which could be 2-4 times longer than the SIJ steroid injection

By comparison, oral semaglutide produced average weight loss of around 13.6% in the OASIS 4 trial, while injectable Wegovy has demonstrated average reductions of approximately 15% in previous studies